Piper Jaffray Companies Weighs in on Senseonics Holdings Inc’s Q1 2019 Earnings (SENS)

Senseonics Holdings Inc (NYSEAMERICAN:SENS) – Equities research analysts at Piper Jaffray Companies reduced their Q1 2019 earnings estimates for Senseonics in a research note issued to investors on Tuesday, March 12th. Piper Jaffray Companies analyst J. Mckim now expects that the company will post earnings of ($0.13) per share for the quarter, down from their prior forecast of ($0.12). Piper Jaffray Companies currently has a “Neutral” rating on the stock. Piper Jaffray Companies also issued estimates for Senseonics’ Q2 2019 earnings at ($0.14) EPS, Q3 2019 earnings at ($0.15) EPS, FY2019 earnings at ($0.56) EPS, Q1 2020 earnings at ($0.12) EPS, Q3 2020 earnings at ($0.14) EPS, Q4 2020 earnings at ($0.14) EPS, FY2020 earnings at ($0.53) EPS and FY2021 earnings at ($0.29) EPS.

Senseonics (NYSEAMERICAN:SENS) last issued its earnings results on Tuesday, March 12th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.11. The business had revenue of $7.20 million for the quarter, compared to the consensus estimate of $7.89 million.



Several other research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Senseonics from a “hold” rating to a “sell” rating in a report on Wednesday, February 6th. UBS Group began coverage on shares of Senseonics in a report on Tuesday, November 27th. They issued a “sell” rating on the stock. Two research analysts have rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $6.00.

Senseonics stock opened at $2.65 on Friday. Senseonics has a fifty-two week low of $2.15 and a fifty-two week high of $5.29.

A number of large investors have recently made changes to their positions in SENS. BlackRock Inc. boosted its position in Senseonics by 6.1% during the fourth quarter. BlackRock Inc. now owns 6,142,950 shares of the company’s stock valued at $15,910,000 after buying an additional 352,590 shares during the period. Vanguard Group Inc boosted its position in Senseonics by 8.7% during the third quarter. Vanguard Group Inc now owns 4,779,370 shares of the company’s stock valued at $22,797,000 after buying an additional 382,058 shares during the period. Vanguard Group Inc. boosted its position in Senseonics by 8.7% during the third quarter. Vanguard Group Inc. now owns 4,779,370 shares of the company’s stock valued at $22,797,000 after buying an additional 382,058 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Senseonics by 19.9% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,696,533 shares of the company’s stock valued at $9,574,000 after buying an additional 613,995 shares during the period. Finally, Janus Henderson Group PLC purchased a new stake in Senseonics during the third quarter valued at about $12,222,000. Institutional investors own 30.66% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Read More: Commodities

Earnings History and Estimates for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.